Dexamethasone Sodium Phosphate (CAS 2392-39-4)
✦ Product Overview
Dexamethasone Sodium Phosphate, a synthetic glucocorticoid with the molecular formula C₂₂H₂₈FNa₂O₈P, is a potent anti-inflammatory and immunosuppressive agent widely used in clinical and research settings. It effectively manages conditions such as severe inflammation, autoimmune disorders, and adrenal insufficiency, while serving as a critical intermediate in pharmaceutical development.
✦ Key Advantages
🔹 Pharmaceutical-Grade Purity: ≥99% verified by HPLC, ensuring reliability in formulations.
🔹 Thermal Stability: Melting point 233–235°C, ideal for stable storage and transport.
🔹 Regulatory Compliance: Meets USP42 and EP9 pharmacopeial standards for global acceptance.
✦ Applications
Clinical Therapy: Treatment of asthma, rheumatoid arthritis, and allergic reactions.
Biomedical Research: Mechanistic studies on glucocorticoid receptor pathways.
Drug Formulation: Key intermediate for injectable solutions and reference standards.
✦ Quality Assurance
Rigorously tested via HPLC, FTIR, and mass spectrometry, with batch-specific Certificates of Analysis (COAs). Stability studies comply with ICH guidelines for long-term storage.
✦ Market Insights
The global glucocorticoid market is projected to grow at 4.8% CAGR (2025–2030), driven by rising demand for advanced anti-inflammatory therapies and targeted drug delivery systems. Dexamethasone Sodium Phosphate remains pivotal in both therapeutic and R&D applications due to its proven efficacy and safety profile.
China
